|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
Greenwich LifeSciences (Nasdaq: GLSI), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, provided an update on the expansion of its clinical trial into Europe. The Company's application to expand Flamingo-01 into Europe has been formally approved by Spain, France, Germany, Italy, and Poland. The academic networks participating in each country are Geicam (Spain), Unicancer (France), GBG (Germany), GIM (Italy), and a network of Polish sites. With this final approval, regulators have cleared the way to activate 105 sites as soon as site contracts and site initiation visits are completed. Site initiation visits have been scheduled as early as the week of March 4, 2024.
|
|
|
|
BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer
BullFrog AI (Nasdaq: BFRG), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced the appointment of Dr. Thomas W. Chittenden, PhD, DPhil, PStat, as its new Chief Scientific Officer. With a distinguished career at the intersection of artificial intelligence, machine learning, drug discovery, and biostatistics, Dr. Chittenden brings a wealth of experience and a proven track record of leadership in scientific research and development to BullFrog AI.
|
|
|
|
|
GreenPower to Showcase its Commercial Vehicles at 2024 Work Truck Week and Host Press Conference
GreenPower Motor Company (Nasdaq: GP), a leading manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space and school bus sector, will attend the National Truck Equipment Association's (NTEA) Work Truck Week in Indianapolis, Indiana on March 5 to 8. Recognized as one of North America's largest work truck events, Work Truck Week provides attendees with the opportunity to network with industry leaders and learn about new products, services and technological developments.
|
|
|
|
|
|
|
Genius Group Expands AI-Powered Genius University
Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, announced the launch of a series of new initiatives to expand its AI-Powered Genius University. Genius Group’s CEO, Roger Hamilton, said “The AI revolution currently taking place will have a deep and irreversible effect on the future of education. The speed of adoption of AI tools to increase learning and productivity has been unprecedented. ChatGPT now has 180 million users, and according to Statista, there were over 250 million users of AI tools and apps in 2023, with this number expected to triple to over 700 million by 2030.”
|
|
|
|
|
Biotricity Receives Health Canada Clearance for Biotres
Biotricity (Nasdaq: BTCY), a leading medical diagnostic and consumer healthcare technology company, proudly announced its Health Canada approval for expansion into the US$1.56 billion Canadian Cardiology Devices market. Cardiovascular disease imposes a staggering US$21.2 billion annual cost in Canada alone, accounting for 11.6% of the entire Canadian health care cost, the approval of Biotres by Health Canada comes at an opportune time.
|
|
|
|
|
|
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
|
|
|
|
Upcoming Events
|
|
|
NASDAQ: BFRG - BullFrog AI
4:15pm Eastern
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine.
|
|
|
|
NASDAQ: ENLV - Enlivex Therapeutics
4:15pm Eastern
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses.
|
|
|
|
Archived Events
|
|
|
NASDAQ: INHD - INNO Holdings
4:15pm Eastern
INNO Holdings is a pioneering building technology company aiming to revolutionize the construction industry with its proprietary cold-formed steel-framing technology and innovative building solutions.
|
|
|
|
Quote of the Week
|
"Knowing when to sell a winner can be a very elusive skill. It often makes sense to keep a small percentage of the shares for idiot’s insurance."
|
|
|
— Byron Roth, ROTH Capital
|
|
|
|
|
RedChip TV
|
|
|
|
RedChip TV Highlights bioAffinity Technologies (NASDAQ: BIAF) & BioVie Inc. (NASDAQ: BIVI) This Week
|
|
|
|
|
|
Better Therapeutics (NASDAQ: BTTX) Groundbreaking Cognitive Behavioral Therapy Platform
|
|
|
|
|
|
Biotricity (NASDAQ: BTCY) Transforming Cardiac Care: Innovative Remote Monitoring Solutions
|
|
|
|
|
|
Lantern Pharma (NASDAQ: LTRN): A.I. & Genomics Revolutionizing Oncology Drug Development
|
|
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Year-end is approaching. This week we have a refresher on the implications of short-term and long-term capital gains.
|
|
|
|
|
|
MidSouth Week in Review
The NASDAQ, Dow and S&P all made new highs. The S&P is now up 15 of the last 17 weeks.
|
|
|
|
|
|
|
|
